The global Tamoxifen Citrate market was valued at approximately USD 570 million in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 5.1% from 2024 to 2031. Growth is being fueled by a rising prevalence of breast cancer, increased focus on preventive oncology, and